$HSTO

Histogen Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.22 ▼-4.31%

Extented Hours

VOLUME

43,664

DAY RANGE

2.2777 - 2.43

52 WEEK

2.06 - 22.8

Join Discuss about HSTO with like-minded investors

profile
@dros #droscrew
recently

+Initiations 8/30: $ADS $AVTR $COOK $DUOL $EWCZ $HSTO $KMT $KRTX $LEVI $MRSN $NRZ $PTRA $RRGB $SITM $SYF $TEAM $WEBR  . -Initiations 8/30: $TPIC

93 Replies 7 👍 15 🔥

profile
@viking #StockTraders.NET
recently

Upside: -CYCN +16% (announces Global Licensing agreement with Akebia Therapeutics for Praliciguat; eligible to receive up to $585M in milestone payments) -SFIX +12% (earnings, guidance) -REVG +10% (earnings, guidance) -CHS +9.9% (earnings, guidance) -EVOK +8.4% (announces FDA Orange Book Listing of U.S. Patent for Gimoti) -ASO +7.2% (earnings, guidance) -MCF +6.6% (to be acquired by Independence Energy in all stock transaction valued at ~$5.7B) -JILL +6.3% (earnings, guidance) -MRVL +5.6% (earnings, guidance) -BYSI +4.8% (announces a Late-Breaking Poster Presentation of PROTECTIVE-2 Phase 3 Data) -THO +4.1% (earnings) -STX +3.7% (raises guidance) -TSLA +2.9% (strong China May passenger vehicle sales) -INO +2.6% (expands partnership with Advaccine to conduct global Phase III efficacy trial of COVID-19 DNA vaccine candidate, INO-4800) -OTLK +2.3% (reports completion of patient dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial) -FTCI +1.4% (earnings, guidance; raising prices) -LUV +1.2% (guidance) Downside: -PLBY -10% (files to offer 4.0M shares) -COUP -8.9% (earnings, guidance; Tony Tiscornia promoted to CFO) -TIGR -7.6% (files to sell 6.5M ADS) -HSTO -7.5% (announces 6.0M share direct offering priced at $1.10/shr) -LESL -5.7% (to sell 24.5M shares for holders) -HQY -5.5% (earnings, guidance) -KDP -4.9% (files to sell 28M common share secondary offering on behalf of Mondelez International) -FTCI -4.7% (earnings, guidance; raising prices) -FSLY -1.7% (hearing Fastly edge CDN platform is having issues causing internet outages) -ETSY -1.3% (files proposed private offering of $1.0B of convertible senior notes) -WBA -1.3% (AMZN reportedly to offer discounted pharmacy services targeting uninsured and those paying cash)

141 Replies 13 👍 12 🔥

Key Metrics

Market Cap

116.88 M

Beta

1.01

Avg. Volume

85.77 K

Shares Outstanding

49.95 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-10

Next Dividend Date

Company Information

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Histogen's innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen's proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

CEO: Steven Mento

Website:

HQ: 10655 Sorrento Valley Road San Diego, 92121 California

Related News